News

Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for ...
A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely ...
Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.
A prospective registry study found a greater risk for infections associated with JAK inhibitors in adolescents and adults with moderate to severe atopic dermatitis compared with biologics.
Lichenification occurs when repeated scratching or rubbing causes skin to thicken and become leathery. Certain skincare and ...
Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that the ...
Verywell Mind on MSN5d
Living With Atopic Dermatitis
The visible symptoms only scratch the surface of this chronic skin condition Living with a chronic condition like atopic ...
Verywell Health on MSN1d
Your Visit: Atopic Dermatitis
If you have atopic dermatitis (eczema), this guide will help you prepare for what to except during your initial doctor's appointment, including questions to ask, tests that might be ordered, and how ...
Nektar Therapeutics (NKTR) stock climbed as Jefferies upgraded the company to buy ahead of a Phase 2b trial readout for ...
In this video, Raj Chovatiya, MD, PhD, discussed continued updates in the use of topical ruxolitinib in pediatric patients with atopic dermatitis.
In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...